Market Cap: $3.57B
CI
CareDx, Inc
CDNA
NASDAQ (NASDAQ Global Market)USD
Market Cap: $3.57B
CareDx (Ticker: CDNA) has recently announced a significant legal development with the dismissal of a longstanding qui tam lawsuit. This resolution represents a pivotal moment for the company, which sp…
CareDx Reports Strong Growth in Q4 Earnings, Advancing Transplant Diagnostics CareDx, a leader in transplant diagnostics, releases its Q4 earnings report, showcasing substantial revenue growth and str…
### CareDx's Strong Q4 Performance Signals Growth in Transplant Diagnostics CareDx (NASDAQ:CDNA) recently announces its Q4 earnings, revealing a strong financial performance that underscores the compa…
CareDx Navigates Complex Healthcare Landscape Amid Mixed Analyst Opinions CareDx, a leader in transplant diagnostics and monitoring solutions, experiences a wave of analytical scrutiny as three financ…
CareDx Navigates a Range of Analyst Opinions Amidst Market Challenges CareDx, a leader in transplant diagnostics and monitoring solutions, currently captures the attention of financial analysts as the…
Navigating Reimbursement Challenges: CareDx's Strategic Shift in Transplant Solutions CareDx, Inc. is currently facing critical challenges stemming from proposed changes in reimbursement policies that…
CareDx Faces Class Action Lawsuit Over Securities Claims CareDx, Inc., a leader in transplant diagnostics, is embroiled in a class action lawsuit filed by the Plumbers & Pipefitters Local Union #295 P…
CareDx Faces Class Action Lawsuit Amidst Securities Litigation CareDx, Inc. is currently embroiled in a class action lawsuit filed by the Plumbers & Pipefitters Local Union #295 Pension Fund. This leg…
Caredx Advances in Transplant Monitoring Technology Caredx, a leader in transplant diagnostics, announces significant advancements in its non-invasive transplant monitoring technology. The company foc…
CareDx: Innovating Transplant Patient Care through Precision Medicine CareDx, Inc., based in Brisbane, California, stands out as a leader in precision medicine solutions specifically tailored for tran…
CareDx Reinforces Commitment to Transplant Patient Care with Innovative Solutions CareDx, Inc., headquartered in Brisbane, California, emerges as a pivotal player in the field of precision medicine, p…
CareDx Reports Strong Growth in Testing Services Amid Financial Forecasts for 2024 CareDx, Inc., recognized as a leader in transplant patient care, announces promising preliminary unaudited financial…
CareDx Advances Precision Medicine at J.P. Morgan Healthcare Conference CareDx, Inc., recognized as The Transplant Company™, is a leader in precision medicine dedicated to enhancing care for transplan…
CareDx Advances Precision Medicine for Transplant Patients CareDx, Inc., a leading precision medicine company based in Brisbane, California, is recognized for its innovative healthcare solutions tailo…
### CareDx Partners with TC BioPharm to Enhance Hematology Oncology Research CareDx, Inc., a prominent precision medicine company based in Brisbane, California, has announced a strategic partnership w…
Strategic Partnership Enhances CareDx's Role in Hematology Oncology CareDx, Inc., a prominent precision medicine company based in Brisbane, California, has forged a significant strategic partnership w…
CareDx Reinforces Commitment to Transplant Medicine Through Upcoming Conferences CareDx, Inc., widely recognized as The Transplant Company™, continues to solidify its position as a leader in precision…
CareDx Enhances Engagement with Stakeholders Through Upcoming Conferences CareDx, Inc., a prominent player in precision medicine focused on transplant care, is set to strengthen its engagement with in…
CareDx Reports Strong Q3 Results and Positive Developments in Testing Services CareDx, Inc. demonstrates significant momentum in its third quarter financial results, reflecting a healthy growth trajec…